Profile: Medarex is a biopharmaceutical company focused on the discovery and development of human antibody-based therapeutics to treat diseases like cancer, inflammation, autoimmune & infectious diseases. Our product Ipilimumab is a Phase III clinical trial product used for the treatment of melanoma and other cancers. MDX-1100 is indicated for ulcerative colitis and rheumatoid arthritis. MDX-066 and MDX-1388 with MBL are used for C. difficile infection. MEDI-545 and MEDI-546 are used for treating lupus and autoimmune diseases. MDX-1342 is indicated for the treatment of chronic lymphocytic leukemia & rheumatoid arthritis. MDX-1106 is used for treating cancer and Hepatitis C. MDX-1203, MDX-1411 and MDX-1203 are ideal for treating cancer.